After many years of success, EvidenceNetwork.ca is no longer in operation. We would like to thank everyone who has contributed to the organization over the past decade including our dedicated researchers, newspaper editors, readers and funders. However, now it is time to move onto new ways of looking at knowledge mobilization and policy. Should you have any questions, please feel free to contact Shannon Sampert at s.sampert@uwinnipeg.ca.

The Canadian public needs to know more is not always better when it comes to healthcare

If you knew that virtually the entire medical community was talking about an issue causing risk and harm to patients across the country, wouldn’t you want to know what it is and take part in the conversation?

It’s time to think even bigger about national pharmacare

Recently federal and provincial health ministers agreed to create a working group to explore how to improve Canadians’ access to pharmaceutical drugs. In the wake of this, there is new optimism that pharmacare, publicly funded and universally available to Canadians, might one day come to pass.

What should be covered by our publicly funded healthcare system?

I am privileged to help patients deal with a variety of common disorders such as ear infections, pharyngitis and sinus inflammation. People suffer a great deal from these problems, especially when they are in the acute phase.